Robert Oliver
Director/Board Member chez PSYBIO THERAPEUTICS CORP.
Fortune : 8 195 $ au 31/03/2024
Profil
Robert L.
Oliver is currently serving as an Independent Director at Exelixis, Inc., Neurotez, Inc., PsyBio Therapeutics Corp., Hyalo Technologies LLC, and a Member-Governors Board at Accreditation Council for Medical Affairs.
Previously, he held the position of President & Chief Executive Officer at Otsuka America Pharmaceutical, Inc. and Otsuka Holdings Co., Ltd.
He also served as the Chief Executive Officer at V ClinBio LLC and Chairman at Otsuka Canada Pharmaceutical, Inc. Additionally, he was an Independent Director at Immunomedics, Inc. and Allarity Therapeutics, Inc. Furthermore, he worked as a Vice President & Global Business Manager-Oncology at Wyeth Pharmaceuticals LLC.
Mr. Oliver completed his undergraduate degree at Rutgers State University of New Jersey and holds an MBA from the Erivan K.
Haub School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PSYBIO THERAPEUTICS CORP
1,63% | 05/01/2023 | 1 365 800 ( 1,63% ) | 8 195 $ | 31/03/2024 |
Postes actifs de Robert Oliver
| Sociétés | Poste | Début |
|---|---|---|
| PSYBIO THERAPEUTICS CORP. | Director/Board Member | 21/04/2021 |
| EXELIXIS, INC. | Director/Board Member | 31/05/2023 |
Neurotez, Inc.
 Neurotez, Inc. BiotechnologyHealth Technology Neurotez, Inc. opertaes as a corporation, which develops leptin product as a novel hormone replacement therapy for alzheimer’s disease. The company was founded by Nikolaos Tezapsidis in 2004 and is headquartered in Bridgewater, NJ. | Director/Board Member | - |
| Hyalo Technologies LLC | Director/Board Member | - |
Anciens postes connus de Robert Oliver
| Sociétés | Poste | Fin |
|---|---|---|
| ALLARITY THERAPEUTICS, INC. | Director/Board Member | 07/08/2023 |
| IMMUNOMEDICS, INC. | Director/Board Member | 16/02/2017 |
| OTSUKA HOLDINGS CO., LTD. | Chief Executive Officer | 01/01/2017 |
V ClinBio LLC
 V ClinBio LLC BiotechnologyHealth Technology V ClinBio LLC operates as an biopharmaceutical company driving the development of novel drug products for treatment of immune and other related diseases. It develops New Molecular Entities using repurposing, incremental innovation and prodrug technology. The company was founded by Subbu Apparsundaram in 2013 and is headquartered in Newark, NJ. | Chief Executive Officer | - |
Otsuka Canada Pharmaceutical, Inc.
 Otsuka Canada Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Canada Pharmaceutical, Inc. is a Canadian healthcare company that commercializes Otsuka medicines in Canada, with a focus on neuroscience and nephrology. The private company is based in Saint-Laurent, Canada and was founded in 1921. The company is dedicated to improving patients' health and the quality of human life. Otsuka Pharmaceutical Co., Ltd., the parent company, is a healthcare company with the corporate philosophy of creating new products for better health worldwide. | Chairman | - |
Formation de Robert Oliver
| Rutgers State University of New Jersey | Undergraduate Degree |
| Erivan K. Haub School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| OTSUKA HOLDINGS CO., LTD. | Health Technology |
| ALLARITY THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Health Technology |
Neurotez, Inc.
Neurotez, Inc. BiotechnologyHealth Technology Neurotez, Inc. opertaes as a corporation, which develops leptin product as a novel hormone replacement therapy for alzheimer’s disease. The company was founded by Nikolaos Tezapsidis in 2004 and is headquartered in Bridgewater, NJ. | Health Technology |
Otsuka Canada Pharmaceutical, Inc.
Otsuka Canada Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Canada Pharmaceutical, Inc. is a Canadian healthcare company that commercializes Otsuka medicines in Canada, with a focus on neuroscience and nephrology. The private company is based in Saint-Laurent, Canada and was founded in 1921. The company is dedicated to improving patients' health and the quality of human life. Otsuka Pharmaceutical Co., Ltd., the parent company, is a healthcare company with the corporate philosophy of creating new products for better health worldwide. | Health Technology |
V ClinBio LLC
V ClinBio LLC BiotechnologyHealth Technology V ClinBio LLC operates as an biopharmaceutical company driving the development of novel drug products for treatment of immune and other related diseases. It develops New Molecular Entities using repurposing, incremental innovation and prodrug technology. The company was founded by Subbu Apparsundaram in 2013 and is headquartered in Newark, NJ. | Health Technology |
| PsyBio Therapeutics Corp. | |
| Hyalo Technologies LLC |
